Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction
Bing‐Xi Yan, Xueyan Chen, Li‐Ran Ye, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Microneedles as a momentous platform for psoriasis therapy and diagnosis: A state-of-the-art review
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Umme Hani, et al.
International Journal of Pharmaceutics (2023) Vol. 632, pp. 122591-122591
Closed Access | Times Cited: 39
From Diagnosis to Treatment: A Review of AI Applications in Psoriasis Management
Eyerusalem Gebremeskel, Gelane Biru, Honey Gemechu, et al.
Journal of Electrical Engineering and Technology (2025)
Closed Access | Times Cited: 1
Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery
Siddharth Singh, Rajendra Awasthi
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104548-104548
Closed Access | Times Cited: 20
Gut microbiota and skin pathologies: Mechanism of the gut-skin axis in atopic dermatitis and psoriasis
Meng Chen, Rui Wang, Ting Wang
International Immunopharmacology (2024) Vol. 141, pp. 112658-112658
Closed Access | Times Cited: 7
Risk Factors for Psoriasis Flares: A Narrative Review
Luca Potestio, Giuseppe Lauletta, Nello Tommasino, et al.
Psoriasis Targets and Therapy (2024) Vol. Volume 14, pp. 39-50
Open Access | Times Cited: 6
Bidirectional Association Between Psoriasis and Nonalcoholic Fatty Liver Disease: Real-World Evidence From Two Longitudinal Cohort Studies
Shuo‐Yan Gau, Kuang‐Hua Huang, Chiu‐Hsiang Lee, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Nano transdermal system combining mitochondria-targeting cerium oxide nanoparticles with all-trans retinoic acid for psoriasis
Wei Wang, Xinyi Xu, Yanling Song, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 5, pp. 100846-100846
Open Access | Times Cited: 14
Cytokines in psoriasis: From pathogenesis to targeted therapy
Manahel Mahmood Alsabbagh
Human Immunology (2024) Vol. 85, Iss. 4, pp. 110814-110814
Closed Access | Times Cited: 5
Decoy oligodeoxynucleotides: A promising therapeutic strategy for inflammatory skin disorders
Maryam Mahjoubin‐Tehran, Samaneh Rezaei, Sercan Karav, et al.
Human Immunology (2024) Vol. 85, Iss. 6, pp. 111161-111161
Closed Access | Times Cited: 5
Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching
Giovanni Damiani, Giulia Odorici, Alessia Pacifico, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 1, pp. 95-95
Open Access | Times Cited: 17
The ‘inflammazone’ in chronic inflammatory diseases: psoriasis and sarcoidosis
Phei Er Saw, Erwei Song
Trends in Immunology (2025)
Closed Access
HiGMA-DADCN: Hirudinaria granulosa multitropic algorithm optimised double attention enabled deep convolutional neural network for psoriasis classification
C S Soumya, H. S. Jayanna
Computer Methods in Biomechanics and Biomedical Engineering Imaging & Visualization (2025) Vol. 13, Iss. 1
Open Access
Latin American consensus on psoriasis severity classification
Ángela Londoño, Juan Raúl Castro-Ayarza, Manuel Darío Franco Franco, et al.
Anais Brasileiros de Dermatologia (2025)
Open Access
Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies
Jiangmei Xu, Hao Chen, Haisheng Qian, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11
The study of GSDMB in pathogenesis of psoriasis vulgaris
Xiaojuan Ji, Huaqing Chen, Ling Xie, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0279908-e0279908
Open Access | Times Cited: 6
Resistin serum levels and its association with clinical profile and carotid intima-media thickness in psoriasis: a cross-sectional study
Sofia Makishi Schlenker, Sofia Inez Munhoz, André Rochinski Busanello, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 6, pp. 799-805
Open Access | Times Cited: 6
Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide
W. P. Andrew Lee, Kyung-Ho Nam, Jong Hoon Kim, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Evidence on the therapeutic role of thiolutin in imiquimod‐induced psoriasis‐like skin inflammation in mice
Aixue Wang, Xixing Ma, Feng Wei, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 5
Exploring the potential of nanocarriers in antipsoriatic therapeutics
Mohammad Shaif, Poonam Kushwaha, Shazia Usmani, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 7, pp. 2919-2930
Closed Access | Times Cited: 7
Pulse azathioprine (AZA) and low dose methotrexate (MTX) versus standard dose MTX in treatment of patients with moderate to severe psoriasis, a randomized controlled trial
Mohamed H.M. El-Komy, Khadiga S. Sayed, Gehad Gawish, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 9, pp. 1029-1035
Closed Access | Times Cited: 1
Risk factors and early detection of joint damage in patients with psoriasis: a case–control study
Amin Yao, Li Wang, Fei Qi, et al.
International Journal of Dermatology (2024) Vol. 63, Iss. 12, pp. 1728-1734
Closed Access | Times Cited: 1
A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs
Rebecca R Reese, Shiva Ram Nanavath, Jennifer L. Martin, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Liposomes and Their Therapeutic Applications in Enhancing Psoriasis and Breast Cancer Treatments
Amal Elkordy, David S. Hill, Mohamed Attia, et al.
Nanomaterials (2024) Vol. 14, Iss. 21, pp. 1760-1760
Open Access | Times Cited: 1
Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study
Andrea Luengas‐Martinez, Dina Ismail, Ralf Paus, et al.
Skin Health and Disease (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 3
Rosmarinic acid ameliorated psoriatic skin inflammation in mice through the novel inhibition of the interleukin-17A/interleukin-17A receptor interaction
Tin‐Yun Ho, Hsin‐Yi Lo, I-Chen Liu, et al.
Food & Function (2022) Vol. 13, Iss. 12, pp. 6802-6812
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top